In this paper, we aim to comprehensively expound upon the mechanisms through which IL-6 contributes to the onset and progression of pancreatic cancer, while also highlighting potential directions for clinical treatment of the disease. The gene discussed is IL6; the disease is pancreatic neoplasm.